Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Villuela, J. Cifrian, B. Abascal, A. Daly, C. Amado, S. Fernandez-Rozas, D. Iturbe, F. Zurbano, R. Mons, J. Gomez-Román (Santander, Spain). Pathological findings in histiocytosis X with pulmonary hypertension. Eur Respir J 2012; 40: Suppl. 56, 3677

Member's Comments

No comment yet.

Related content which might interest you: Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Clinical course and outcome of pulmonary Langerhans‘-cell histiocytosis Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Pulmonary hypertension in pulmonary Langerhans’ cell histiocytosis Source: Eur Respir Mon 2012; 57: 161-165 Year: 2012 Pulmonary hypertension in orphan lung diseases Source: Eur Respir Mon 2011; 54: 317-331 Year: 2011 A case with pulmonary histiocytosis X and lung cancer Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Clinical and pathological features of 13 adult patients with pulmonary Langerhans‘ cell histiocytosis Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Severe pulmonary hypertension in histiocytosis X: long-term improvement with bosentan Source: Eur Respir J 2010; 36: 202-204 Year: 2010 Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Special features in progress of cases with pulmonary histiocytosis X Source: Eur Respir J 2002; 20: Suppl. 38, 59s Year: 2002 Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Pulmonary histiocytosis triggered by marijuana- and nicotine-abuse Source: Eur Respir J 2002; 20: Suppl. 38, 338s Year: 2002 Radiologic finding of pulmonary vasculitis Source: Annual Congress 2009 - Old and new: technique and pathology Year: 2009 Pulmonary Langerhans histiocytosis: clinical, radiological and functional pattern in spontaneous remission Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Pulmonary Langerhans‘-cell histiocytosis – clinical futures and outcome Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Pulmonary Langerhans' cell histiocytosis Source: Respipedia Article Year: 2016 Imaging of pulmonary histiocytosis X , report of 10 cases Source: Eur Respir J 2004; 24: Suppl. 48, 489s Year: 2004 Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH) Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Neoplastic markers in pulmonary sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004 Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Genetic landscape of pulmonary langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018